Targeting of the COX-2/PGE2 axis enhances the antitumor activity of T7 peptide in vitro and in vivo-Reference-Cited by-同舟云学术

Targeting of the COX-2/PGE2 axis enhances the antitumor activity of T7 peptide in vitro and in vivo

Published:2021-01-01 Issue:1 Volume:28 Page:844-855
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Yang Jianrong¹,Zhong Jingtao²,Zhou Mi³,Zhou Yinghong⁴,Xiu Peng⁵,Liu Feng⁵,Wang Fuhai⁵,Li Zelun¹,Tang Yuntian¹,Chen Yuanyuan¹,Yao Siyang¹,Huang Tao¹,Liu Tianqi¹,Dong Xiaofeng¹

Affiliation:

1. Department of Hepatobiliary, Pancreas and Spleen Surgery, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China

2. Department of Hepatobiliary Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China

3. Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China

4. School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan, China

5. Department of General Surgery, Shandong Provincial Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Jinan, China

Funder

National Natural Science Foundation of China

the Natural Science Foundation of Guangxi Zhuang Autonomous Region

Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor

the Self-financed Research Program of Health and Family Planning Commission of Guangxi Zhuang Autonomous Region

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2021.1914776

Reference43 articles.